Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CLOPIDOGREL BISULFATE Cause Blindness transient? 27 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Blindness transient have been filed in association with CLOPIDOGREL BISULFATE (Clopidogrel). This represents 0.1% of all adverse event reports for CLOPIDOGREL BISULFATE.

27
Reports of Blindness transient with CLOPIDOGREL BISULFATE
0.1%
of all CLOPIDOGREL BISULFATE reports
0
Deaths
4
Hospitalizations

How Dangerous Is Blindness transient From CLOPIDOGREL BISULFATE?

Of the 27 reports, 4 (14.8%) required hospitalization, and 1 (3.7%) were considered life-threatening.

Is Blindness transient Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CLOPIDOGREL BISULFATE. However, 27 reports have been filed with the FAERS database.

What Other Side Effects Does CLOPIDOGREL BISULFATE Cause?

Gastrointestinal haemorrhage (5,513) Anaemia (3,043) Dyspnoea (1,963) Drug interaction (1,846) Haemorrhage (1,762) Drug ineffective (1,644) Cerebral haemorrhage (1,603) Dizziness (1,586) Epistaxis (1,560) Melaena (1,547)

What Other Drugs Cause Blindness transient?

AFLIBERCEPT (987) ADALIMUMAB (200) METFORMIN (153) DIMETHYL (119) INTERFERON BETA-1A (102) NATALIZUMAB (101) RANIBIZUMAB (100) BROLUCIZUMAB-DBLL (99) FINGOLIMOD (89) BEVACIZUMAB (72)

Which CLOPIDOGREL BISULFATE Alternatives Have Lower Blindness transient Risk?

CLOPIDOGREL BISULFATE vs CLORAZEPATE CLOPIDOGREL BISULFATE vs CLOSTRIDIUM TETANI TOXOID ANTIGEN CLOPIDOGREL BISULFATE vs CLOTHIAPINE CLOPIDOGREL BISULFATE vs CLOTIAZEPAM CLOPIDOGREL BISULFATE vs CLOTRIMAZOLE

Related Pages

CLOPIDOGREL BISULFATE Full Profile All Blindness transient Reports All Drugs Causing Blindness transient CLOPIDOGREL BISULFATE Demographics